BORGESON BLAKE sold 2.6% of their position (170K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $588.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001601830-26-000045
Director
Since Apr 2021
-170K
Net shares
Net seller
$588.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
170K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−170K
Price / share
$3.46
Trade value
$588.20K
% of position
2.6%
3/3/2026
6.43M→6.26M
Total
Net shares
−170K
Net value
-$588.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/3/2026 | S · Sale | −170K | $3.46 | $588.20K | 2.6% | 6.43M | 6.26M |
| Total | −170K | -$588.20K | ||||||
Derivative Transactions0
No derivative transactions reported